These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 2194674)

  • 1. Inhibition of purified p21ras farnesyl:protein transferase by Cys-AAX tetrapeptides.
    Reiss Y; Goldstein JL; Seabra MC; Casey PJ; Brown MS
    Cell; 1990 Jul; 62(1):81-8. PubMed ID: 2194674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetrapeptide inhibitors of protein farnesyltransferase: amino-terminal substitution in phenylalanine-containing tetrapeptides restores farnesylation.
    Brown MS; Goldstein JL; Paris KJ; Burnier JP; Marsters JC
    Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8313-6. PubMed ID: 1518863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyisoprenylation of Ras in vitro by a farnesyl-protein transferase.
    Schaber MD; O'Hara MB; Garsky VM; Mosser SC; Bergstrom JD; Moores SL; Marshall MS; Friedman PA; Dixon RA; Gibbs JB
    J Biol Chem; 1990 Sep; 265(25):14701-4. PubMed ID: 2203759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence requirement for peptide recognition by rat brain p21ras protein farnesyltransferase.
    Reiss Y; Stradley SJ; Gierasch LM; Brown MS; Goldstein JL
    Proc Natl Acad Sci U S A; 1991 Feb; 88(3):732-6. PubMed ID: 1992464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonidentical subunits of p21H-ras farnesyltransferase. Peptide binding and farnesyl pyrophosphate carrier functions.
    Reiss Y; Seabra MC; Armstrong SA; Slaughter CA; Goldstein JL; Brown MS
    J Biol Chem; 1991 Jun; 266(16):10672-7. PubMed ID: 2037606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of a mammalian protein geranylgeranyltransferase. Formation and catalytic properties of an enzyme-geranylgeranyl pyrophosphate complex.
    Yokoyama K; Gelb MH
    J Biol Chem; 1993 Feb; 268(6):4055-60. PubMed ID: 8440698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent inhibition of human tumor p21ras farnesyltransferase by A1A2-lacking p21ras CA1A2X peptidomimetics.
    Nigam M; Seong CM; Qian Y; Hamilton AD; Sebti SM
    J Biol Chem; 1993 Oct; 268(28):20695-8. PubMed ID: 8407887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel tricyclic inhibitors of farnesyl protein transferase. Biochemical characterization and inhibition of Ras modification in transfected Cos cells.
    Bishop WR; Bond R; Petrin J; Wang L; Patton R; Doll R; Njoroge G; Catino J; Schwartz J; Windsor W
    J Biol Chem; 1995 Dec; 270(51):30611-8. PubMed ID: 8530497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of alpha-subunit of protein farnesyltransferase. Evidence for a catalytic role.
    Andres DA; Goldstein JL; Ho YK; Brown MS
    J Biol Chem; 1993 Jan; 268(2):1383-90. PubMed ID: 8419339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of farnesyl transferases from malignant and non-malignant cultured human lymphocytes by prenyl substrate analogues.
    Das NP; Allen CM
    Biochem Biophys Res Commun; 1991 Dec; 181(2):729-35. PubMed ID: 1755854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different analogues of farnesyl pyrophosphate inhibit squalene synthase and protein:farnesyltransferase to different extents.
    Cohen LH; Valentijn AR; Roodenburg L; Van Leeuwen RE; Huisman RH; Lutz RJ; Van der Marel GA; Van Boom JH
    Biochem Pharmacol; 1995 Mar; 49(6):839-45. PubMed ID: 7702642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonfarnesylated tetrapeptide inhibitors of protein farnesyltransferase.
    Goldstein JL; Brown MS; Stradley SJ; Reiss Y; Gierasch LM
    J Biol Chem; 1991 Aug; 266(24):15575-8. PubMed ID: 1874715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rab geranylgeranyl transferase. A multisubunit enzyme that prenylates GTP-binding proteins terminating in Cys-X-Cys or Cys-Cys.
    Seabra MC; Goldstein JL; Südhof TC; Brown MS
    J Biol Chem; 1992 Jul; 267(20):14497-503. PubMed ID: 1321151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional consequence of mutating conserved residues of the yeast farnesyl-protein transferase beta-subunit Ram1(Dpr1).
    Kurth DD; Farh L; Deschenes RJ
    Biochemistry; 1997 Dec; 36(50):15932-9. PubMed ID: 9398327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein farnesyltransferase: measurement of enzymatic activity in 96-well format using TopCount microplate scintillation counting technology.
    Harwood HJ
    Anal Biochem; 1995 Apr; 226(2):268-78. PubMed ID: 7793628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and structural requirements of potent peptidomimetic inhibitors of p21ras farnesyltransferase.
    Qian Y; Blaskovich MA; Saleem M; Seong CM; Wathen SP; Hamilton AD; Sebti SM
    J Biol Chem; 1994 Apr; 269(17):12410-3. PubMed ID: 8175645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geranylgeranyl diphosphate synthase catalyzing the single condensation between isopentenyl diphosphate and farnesyl diphosphate.
    Sagami H; Korenaga T; Ogura K
    J Biochem; 1993 Jul; 114(1):118-21. PubMed ID: 8407863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posttranslational modification of Ha-ras p21 by farnesyl versus geranylgeranyl isoprenoids is determined by the COOH-terminal amino acid.
    Kinsella BT; Erdman RA; Maltese WA
    Proc Natl Acad Sci U S A; 1991 Oct; 88(20):8934-8. PubMed ID: 1924354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Xenopus laevis oocyte farnesyl transferase.
    Goalstone ML; Diamond CL; Sadler SE
    Biol Reprod; 1996 Mar; 54(3):675-81. PubMed ID: 8835391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Farnesyl protein transferase inhibitors as potential cancer chemopreventives.
    Kelloff GJ; Lubet RA; Fay JR; Steele VE; Boone CW; Crowell JA; Sigman CC
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):267-82. PubMed ID: 9107432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.